A Trap In Measuring Of Plasma Digoxin Level After Stopping Of A Treatment
DOI:
https://doi.org/10.47144/phj.v28i1-2.208Keywords:
Measuring Of PlasmaAbstract
Summary:
In this paper, a course of the disease of a 68year-old patient treated with medigoxin for congestive heart failure is presented. After being withdrawn from his treatment at the hospital, the patient was administered spironolactone and turosemide. The plasma digoxin level at entry was 1.1 nmol/L, after five days it reached 3.2nmol/L, and after ten days was 2.3 nmol/L. The patient had a normal renal function. The interference of spironolactone and its metabolites with the thgoxin ‘radioimmunoassay was discussed as a possible explanation for this omena.
The case described here demonstrates a pr entation of a 68year-old patient with cardiac d compensation who had been treated with 0.1 mgo medigoxin daily for congestive heart failure until the admission to the hospital. On entry an e1ecu cardiogram indicated the PQinterva1 of 0.38 , suggesting the digitalis effect. During the treau the clinical picture of heart failure disappeare while plasma digoxin concentration disclosed highei and higher values, despite the withdrawal of’ medigoxin.
Downloads
Downloads
How to Cite
Issue
Section
License
When an article is accepted for publication in the print format, the author will be required to transfer exclusive copyright to the PHJ and retain the rights to use and share their published article with others. However, re-submission of the full article or any part for publication by a third party would require prior permission of the PHJ.
Online publication will allow the author to retain the copyright and share the article under the agreement described in the licensing rights with creative commons, with appropriate attribution to PHJ. Creative Commons attribution license CC BY 4.0 is applied to articles published in PHJ https://creativecommons.org/licenses/by/4.0/
